In our prospective study of patients with HNSCC, we found higher levels of serum MT associated with increased FGF19 levels in tumor tissues, but these patients did not show a good correlation between the concentrations of serum MT and FGF19, suggesting MT is most likely involved in FGF19 upregulation in tumor cells. Here, FGF19 is linked to neoplasm.